1. CMV Seropositivity and Viremia Drive T-Cell Reconstitution after CD34-Selected Allogeneic HCT 
Christina Cho, Patrick Hilden, Ioannis Politikos, Taylor Borrill, Cristi Ciolino, Sean M. Devlin, Molly Maloy, Katherine Smith, Sergio A. Giralt, Richard J. O'Reilly, Marcel R.M. van den Brink, Miguel-Angel Perales 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 3, Pages S162-S163 (March 2017)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
T-cell subsets at 120 ± 30 days post-TCD PBSCT by CMV serostatus and viremia within 60 days of transplant.
Biology of Blood and Marrow Transplantation  , S162-S163DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
Total CD8 cells by CMV serostatus and viremia within 60 days of TCD PBSCT.
Biology of Blood and Marrow Transplantation  , S162-S163DOI: ( /j.bbmt )
Copyright © Terms and Conditions

4. Figure 3
CD8 effector memory cells by CMV serostatus and viremia within 60 days of TCD PBSCT.
Biology of Blood and Marrow Transplantation  , S162-S163DOI: ( /j.bbmt )
Copyright © Terms and Conditions